Waldenström Lifetime Achievement Award
Named for Jan Waldenström, a pioneer in treating blood cancers, the Waldenström Lifetime Achievement Award has been given by the IMS at each International Myeloma Workshop since 1989. This award is given to outstanding researchers in recognition of their long term contributions to the myeloma field.
Recipient Profile
Dr Sundar Jagannath is the Director of the Multiple Myeloma Center of Excellence at Tisch Cancer Institute, Mount Sinai Hospital, New York, NY. He is also Professor of Medicine and Mount Sinai Endowed Chair for Multiple Myeloma at Mount Sinai School of Medicine.
A renowned expert in Multiple Myeloma and Bone Marrow Transplantation, Dr Jagannath has published extensively on these topics and is often an invited presenter at professional organizations’ annual meetings. He is editor-in-chief of Clinical Lymphoma, Myeloma & Leukemia and a peer reviewer for many other journals. Dr Jagannath is a board member for the Society of Hematologic Oncology. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology. In 2003, Dr Jagannath received the Humanitarian Award from the Multiple Myeloma Research Foundation, and in 2006, 2009, and 2010 he was the recipient of the Foundation’s Laugh for Life Award. In 2017, Dr. Jagannath received the Innovator Award from the Multiple Myeloma Research Consortium (MMRC). In, 2018 Dr. Jagannath received the Fellow of the American Society of Clinical Oncology Award (FASCO). Most recently, in 2022 Dr. Jagannath was the recepient in The SASS Foundation for Medical Research Award: Michaeli Award for Outstanding Contributions to Myeloma.
Past Recipients
- 1989 – D. Bergsagel – deceased (April 25, 1925 – October 20, 2007)
- 1991 – R. Kyle
- 1993 – S. Salmon – deceased (May 8, 1936-October 6, 1999)
- 1995 – M. Potter – deceased (February 27, 1924 – June 18, 2013)
- 1997 – R. Alexanian
- 1999 – B. Barlogie
- 2001 – H. Mellstedt
- 2003 – K. Anderson
- 2005 – J-L Harousseau
- 2007 – J. San Miguel
- 2009 – B. Durie
- 2011 – W. M. Kuehl
- 2013 – N. Munshi
- 2015 – M. Attal
- 2017 – M. A. Dimopoulos
- 2019 – G. Merlini
- 2021 – S. Vincent Rajkumar
- 2022 – P. Sonneveld
- 2023 – S. Jagannath
Why Become a Member
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.
